BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 10720071)

  • 21. The antilipolytic action of insulin in obese subjects with resistance to its glucoregulatory action.
    Howard BV; Klimes I; Vasquez B; Brady D; Nagulesparan M; Unger RH
    J Clin Endocrinol Metab; 1984 Mar; 58(3):544-8. PubMed ID: 6363441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitation of forearm glucose and free fatty acid (FFA) disposal in normal subjects and type II diabetic patients: evidence against an essential role for FFA in the pathogenesis of insulin resistance.
    Capaldo B; Napoli R; Di Marino L; Picardi A; Riccardi G; Sacca L
    J Clin Endocrinol Metab; 1988 Nov; 67(5):893-8. PubMed ID: 3053749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of free fatty acids on plasma resistin and insulin resistance in awake rats.
    Yang G; Li L; Fang C; Zhang L; Li Q; Tang Y; Boden G
    Metabolism; 2005 Sep; 54(9):1142-6. PubMed ID: 16125524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of graded hyperglycemia with and without physiological hyperinsulinemia on forearm glucose uptake and other metabolic responses in man.
    Jackson RA; Hamling JB; Blix PM; Sim BM; Hawa MI; Jaspan JB; Belin J; Nabarro JD
    J Clin Endocrinol Metab; 1986 Sep; 63(3):594-604. PubMed ID: 2874153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of insulin and free fatty acid (FFA) availability on regional FFA kinetics in the human forearm.
    Capaldo B; Napoli R; Di Marino L; Guida R; Pardo F; Saccá L
    J Clin Endocrinol Metab; 1994 Sep; 79(3):879-82. PubMed ID: 8077375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of superphysiologic hyperinsulinemia on glucose and lipid metabolism in glucose-tolerant offspring of patients with non-insulin-dependent diabetes mellitus (NIDDM).
    Osei K
    Diabetes Res Clin Pract; 1992 Sep; 17(3):169-82. PubMed ID: 1425156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resistance to insulin suppression of plasma free fatty acid concentrations and insulin stimulation of glucose uptake in noninsulin-dependent diabetes mellitus.
    Chen YD; Golay A; Swislocki AL; Reaven GM
    J Clin Endocrinol Metab; 1987 Jan; 64(1):17-21. PubMed ID: 3782431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma leptin concentrations do not appear to decrease insulin-mediated glucose disposal or glucose-stimulated insulin secretion in women with normal glucose tolerance.
    Carantoni M; Abbasi F; Azhar S; Chen YD; Klebanov M; Wang PW; Warmerdam F; Reaven GM
    Diabetes; 1998 Feb; 47(2):244-7. PubMed ID: 9519720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma free fatty acid concentration during hyperglycemic glucose clamp with and without somatostatin infusion in obese subjects with normal glucose tolerance.
    Zancanaro C; Cigolini M; Bonora E; Moghetti P; Cacciatori V; Querena M; Muggeo M
    Int J Obes; 1990 Jul; 14(7):551-7. PubMed ID: 1977721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin sensitivity of blood glucose versus insulin sensitivity of blood free fatty acids in normal, obese, and obese-diabetic subjects.
    Belfiore F; Iannello S; Camuto M; Fagone S; Cavaleri A
    Metabolism; 2001 May; 50(5):573-82. PubMed ID: 11319720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ambient plasma free fatty acid concentrations in noninsulin-dependent diabetes mellitus: evidence for insulin resistance.
    Fraze E; Donner CC; Swislocki AL; Chiou YA; Chen YD; Reaven GM
    J Clin Endocrinol Metab; 1985 Nov; 61(5):807-11. PubMed ID: 3900120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Further evidence for a central role of adipose tissue in the antihyperglycemic effect of metformin.
    Abbasi F; Carantoni M; Chen YD; Reaven GM
    Diabetes Care; 1998 Aug; 21(8):1301-5. PubMed ID: 9702437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.
    Kotronen A; Juurinen L; Tiikkainen M; Vehkavaara S; Yki-Järvinen H
    Gastroenterology; 2008 Jul; 135(1):122-30. PubMed ID: 18474251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum aldosterone changes during hyperinsulinemia are correlated to body mass index and insulin sensitivity in patients with essential hypertension.
    Haenni A; Reneland R; Lind L; Lithell H
    J Hypertens; 2001 Jan; 19(1):107-12. PubMed ID: 11204289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperinsulinemia compensates for infection-induced impairment in net hepatic glucose uptake during TPN.
    Donmoyer CM; Chen SS; Hande SA; Lacy DB; Ejiofor J; McGuinness OP
    Am J Physiol Endocrinol Metab; 2000 Aug; 279(2):E235-43. PubMed ID: 10913021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gender-related differences in the metabolic response to fasting.
    Soeters MR; Sauerwein HP; Groener JE; Aerts JM; Ackermans MT; Glatz JF; Fliers E; Serlie MJ
    J Clin Endocrinol Metab; 2007 Sep; 92(9):3646-52. PubMed ID: 17566089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resistance to insulin-mediated glucose uptake and hyperinsulinemia in women who had preeclampsia during pregnancy.
    Fuh MM; Yin CS; Pei D; Sheu WH; Jeng CY; Chen YI; Reaven GM
    Am J Hypertens; 1995 Jul; 8(7):768-71. PubMed ID: 7546505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of insulin resistance and hyperinsulinemia with disturbed lipid metabolism in patients with essential hypertension.
    Agata J; Miyazaki Y; Takada M; Murakami H; Masuda A; Miura T; Ura N; Shimamoto K
    Hypertens Res; 1998 Mar; 21(1):57-62. PubMed ID: 9582109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucagon does not increase plasma free fatty acid and glycerol concentrations in patients with noninsulin-dependent diabetes mellitus.
    Jeng CY; Sheu WH; Jaspan JB; Polonsky KS; Chen YD; Reaven GM
    J Clin Endocrinol Metab; 1993 Jul; 77(1):6-10. PubMed ID: 8100832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of IGF-I on FFA and glucose metabolism in control and type 2 diabetic subjects.
    Pratipanawatr T; Pratipanawatr W; Rosen C; Berria R; Bajaj M; Cusi K; Mandarino L; Kashyap S; Belfort R; DeFronzo RA
    Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1360-8. PubMed ID: 12006367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.